4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-000988
Director gave up 4,301 shares (to pay taxes)
- Director acquired 17,258 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CANNON JAMES ANTHONY Director | 2017-12-29 | Grant or award | +17,258 | 391,666 | D | ||
| CANNON JAMES ANTHONY Director | 2017-12-30 | Shares withheld for taxes | −4,301 | $4.14 | $17,806 | 387,365 | D |
Loading xslF345X03/doc4.xml…